| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2011 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | 1,3 M € | +10.2% | 1,2 M € | +10.0% | 1,1 M € | +16.5% | 927,6 k € | — | — | — | ||||||||||||||
| Gross margin | 520,3 k € | +2.1% | 509,3 k € | +10.5% | 460,8 k € | +72.7% | 266,8 k € | +11.2% | 239,9 k € | +9.2% | 219,6 k € | +22.6% | 179,2 k € | +30.1% | 137,7 k € | +35.0% | 102,0 k € | +12.9% | 90,4 k € | — | — | — | — | 80,0 k € | -78.7% | 375,0 k € | +882.9% | -47,9 k € | ||||||
| EBITDA | 6,8 k € | -3.4% | 7,0 k € | -86.7% | 52,5 k € | -23.1% | 68,3 k € | +28.8% | 53,0 k € | +5802.1% | 898,8 € | +280.1% | -499,0 € | +98.7% | -39,8 k € | +43.4% | -70,5 k € | +34.1% | -106,9 k € | +45.7% | -196,7 k € | -8.4% | -181,4 k € | -57.3% | -115,3 k € | +30.9% | -167,0 k € | -31.6% | -126,9 k € | -172.3% | 175,4 k € | +229.1% | -135,9 k € | |
| Operating profit | 6,7 k € | -3.8% | 7,0 k € | -86.7% | 52,5 k € | -23.1% | 68,3 k € | +28.8% | 53,0 k € | +989.6% | 4,9 k € | -70.5% | 16,5 k € | +132.0% | -51,6 k € | +31.2% | -74,9 k € | +24.5% | -99,3 k € | +51.1% | -203,0 k € | -9.3% | -185,7 k € | -59.6% | -116,3 k € | +41.8% | -200,0 k € | -54.7% | -129,3 k € | -175.0% | 172,4 k € | +225.8% | -137,0 k € | |
| Profit/loss | 1,9 k € | +30.5% | 1,4 k € | -96.0% | 35,7 k € | -24.9% | 47,6 k € | +33.7% | 35,6 k € | +3361.1% | 1,0 k € | -87.9% | 8,5 k € | +1047.4% | 742,3 € | +18.2% | 628,3 € | -79.4% | 3,1 k € | +503.1% | -758,0 € | -112.5% | 6,1 k € | +163.9% | -9,5 k € | -107.6% | 124,8 k € | +190.3% | -138,2 k € | -190.8% | 152,3 k € | +208.0% | -141,0 k € | |
| Equity | 148,3 k € | +1.3% | 146,5 k € | +1.0% | 145,1 k € | +32.7% | 109,3 k € | +77.0% | 61,8 k € | +136.0% | 26,2 k € | +4.1% | 25,1 k € | +51.2% | 16,6 k € | +4.7% | 15,9 k € | +4.1% | 15,3 k € | +63.5% | 9,3 k € | -7.5% | 10,1 k € | — | — | -124,8 k € | -1028.6% | 13,4 k € | +109.7% | -138,9 k € | ||||
| Total assets | 900,0 k € | -19.2% | 1,1 M € | +9.5% | 1,0 M € | +5.3% | 966,4 k € | -4.0% | 1,0 M € | +11.5% | 903,3 k € | +3.1% | 875,9 k € | +0.9% | 867,8 k € | +3.2% | 840,8 k € | +3.9% | 809,0 k € | +8.9% | 742,7 k € | -0.7% | 748,3 k € | +26.4% | 592,1 k € | -3.4% | 612,9 k € | -12.0% | 696,6 k € | +18.6% | 587,4 k € | +126.2% | 259,7 k € | |
| Cash | 97,9 k € | +64.8% | 59,4 k € | -20.9% | 75,1 k € | -7.5% | 81,1 k € | -24.5% | 107,5 k € | +0.5% | 106,9 k € | +30.7% | 81,8 k € | +9.8% | 74,5 k € | -34.7% | 114,0 k € | +56.1% | 73,0 k € | +3.4% | 70,7 k € | +4.7% | 67,5 k € | +24.4% | 54,2 k € | -8.9% | 59,5 k € | -59.2% | 146,0 k € | +268.8% | 39,6 k € | +125.6% | 17,6 k € | |
| Debts | 727,7 k € | -23.4% | 949,9 k € | +11.2% | 854,2 k € | +1.9% | 838,7 k € | -10.1% | 932,5 k € | +8.6% | 858,3 k € | +2.6% | 836,9 k € | -0.8% | 843,6 k € | +3.1% | 818,3 k € | +4.6% | 782,3 k € | +7.3% | 728,8 k € | +0.2% | 727,7 k € | +24.0% | 586,7 k € | -1.8% | 597,3 k € | -27.1% | 819,2 k € | +43.4% | 571,3 k € | +44.2% | 396,1 k € | |
| Staff | 2,3 | 2 | 2 | 2 | 2,3 | 3 | 2,3 | 2 | 2 | 2,1 | 2,8 | 3 | 2 | 2,5 | 2 | 3 | 1,9 | |||||||||||||||||
Private limited company · Liège · incorporated on 21/12/2004 · 2,3 ETP
Private limited company profitable and well capitalised. Cash position rising (+64.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CAIR BELGIUM is a Private limited company incorporated in 2004. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Liège. It employs on average 2,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette